Polypharmacy Increases Risk of Dyspnea Among Adults With Serious, Life-Limiting Diseases.

CONCLUSION: Polypharmacy was strongly associated with dyspnea. Prospective interventions to decrease polypharmacy may impact dyspnea symptoms, especially for statins. PMID: 31550901 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31550901?dopt=Abstract

Source: The American Journal of Hospice and Palliative Care - September 23, 2019 Category: Palliative Care Authors: Akgün KM, Krishnan S, Feder SL, Tate J, Kutner JS, Crothers K Tags: Am J Hosp Palliat Care Source Type: research